Fig. 3.
Geometric mean cumulative urinary excretion of afatinib (%) after single-dose afatinib 50 mg in subjects with a mild and b moderate hepatic impairment compared with matched healthy controls
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.